Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Levothyroxine is one of the most commonly prescribed medications in the United States, with over 20 million prescriptions filled annually for hypothyroidism and thyroid disease. If you take levothyroxine and are considering GLP-1 therapy like semaglutide for weight loss, you may have questions about combining these medications safely. The good news: they can typically be used together, but timing and monitoring matter.
How Levothyroxine and Semaglutide Interact
Levothyroxine is a synthetic thyroid hormone that replaces or supplements the body's natural thyroid hormone production. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by slowing stomach emptying and signaling fullness to the brain. These two medications work through completely different biological pathways, and direct chemical interactions between them are rare.
However, semaglutide slows gastric motility—the speed at which food and medications move through your digestive system. This delayed movement can theoretically reduce levothyroxine absorption if both medications are taken too close together. The key to safe concurrent use is proper timing and spacing between doses, which your healthcare provider can recommend based on your specific dosing schedule.
Timing Guidelines for Taking Both Medications Safely
Levothyroxine requires an empty stomach for optimal absorption and should be taken first thing in the morning, ideally 30 to 60 minutes before eating or taking other oral medications. Standard medical practice recommends spacing levothyroxine at least four hours apart from calcium, iron, antacids, and other substances that reduce its bioavailability. Since semaglutide slows gastric emptying, similar spacing principles apply.
If you inject semaglutide, timing is straightforward: take your levothyroxine in the morning on an empty stomach as usual, and administer your weekly semaglutide injection at a different time—typically later in the day or on a different day altogether. If you take oral semaglutide, maintain at least a four-hour gap between your levothyroxine dose and any oral GLP-1 medication. Your PlexusDx provider can help create a medication schedule that works for your routine.
Thyroid Function Monitoring on GLP-1 Therapy
Weight loss itself can influence thyroid hormone levels, independent of any medication interaction. Studies show that significant weight reduction may lower TSH (thyroid-stimulating hormone) and alter thyroid hormone metabolism, sometimes requiring levothyroxine dose adjustments. When you start GLP-1 therapy and lose weight, your thyroid function should be monitored more closely than usual.
PlexusDx recommends checking TSH and free T4 levels within the first three months of starting semaglutide or other GLP-1 medications, and then every six to twelve months thereafter. This proactive monitoring ensures your levothyroxine dose remains optimized as your weight and metabolism change. Your primary care doctor or endocrinologist can order these simple blood tests and adjust your thyroid replacement dose if needed.
Personalized GLP-1 Therapy and Thyroid Health at PlexusDx
PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A compounding pharmacies, with no flat per-compound pricing increases—your dose may need to go up, but your price won't. All PlexusDx medications are available nationwide without insurance requirements or membership fees, and they're HSA and FSA eligible, making precision weight loss therapy accessible.
PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month), which analyzes 14 pathways and 150+ genetic insights including variants affecting GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. Understanding your peptide-pathway genetics helps personalize your GLP-1 therapy plan and anticipate how your body may respond to treatment, including any metabolic factors related to thyroid function. When you have both thyroid disease and weight management goals, this personalized approach matters.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take Ozempic and levothyroxine at the same time of day?
No—space them at least 4 hours apart. Take levothyroxine first thing in the morning on an empty stomach, then administer your GLP-1 medication several hours later or on a different day if you use an injectable. This spacing prevents semaglutide's gastric-slowing effects from reducing levothyroxine absorption.
Will semaglutide make my levothyroxine less effective?
Semaglutide does not chemically interfere with levothyroxine, but it delays stomach emptying, which could reduce levothyroxine absorption if taken too close together. Proper timing eliminates this risk. Additionally, weight loss from GLP-1 therapy may naturally lower TSH levels, requiring levothyroxine dose monitoring.
How much does compounded semaglutide cost at PlexusDx?
Compounded semaglutide injections start at $149 per month at PlexusDx, with pricing that remains flat as your dose increases. No insurance is required, and the medication is HSA and FSA eligible, making it affordable for most patients managing both weight and thyroid health.
Should my TSH levels be checked when starting GLP-1 therapy?
Yes—baseline TSH and free T4 testing should occur within 3 months of starting semaglutide or other GLP-1 medications, then annually. Weight loss can alter thyroid hormone metabolism, potentially requiring levothyroxine dose adjustments. Regular monitoring protects your thyroid health while losing weight.
How can the PlexusDx Precision Peptide Genetic Test help with my thyroid and weight loss?
The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 150+ genetic insights across 14 pathways, including variants in GLP1R and MC4R that affect how your body responds to GLP-1 therapy. Understanding your genetic predispositions helps personalize your treatment plan and anticipate metabolic changes, supporting safer weight loss management alongside thyroid replacement therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Did the FDA Approve Ozempic for Weight Loss?
Where on My Thigh Should I Inject Ozempic?